W Strategies, LLC
14 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
W Strategies, LLC
Federal lobbying records
Bills it lobbied onAll 7
HR 5376 Impacts and Outcomes for Health Career Training Act19 reports · In committeeHR 946 ORPHAN Cures Act14 reports · In committeeHR 1 An act to provide for reconciliation pursuant to title II of H. Con. Res. 1412 reports · Became lawHR 1492 To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program11 reports · In committeeHR 1406 Lung Cancer Screening and Prevention Act of 20255 reports · In committeeHR 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes4 reports · In committeeHR 1990 American Innovation and R&D Competitiveness Act of 20252 reports · In committeeEvery link on this map
The same connections as a table, with the reason each one is here.
| HR 5376 | Bills it lobbied on | W Strategies, LLC named HR 5376, “Impacts and Outcomes for Health Career Training Act”, in 19 lobbying reports. | 19 reports |
| HR 946 | Bills it lobbied on | W Strategies, LLC named HR 946, “ORPHAN Cures Act”, in 14 lobbying reports. | 14 reports |
| HR 1 | Bills it lobbied on | W Strategies, LLC named HR 1, “An act to provide for reconciliation pursuant to title II of H. Con. Res. 14”, in 12 lobbying reports. | 12 reports |
| HR 1492 | Bills it lobbied on | W Strategies, LLC named HR 1492, “To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program”, in 11 lobbying reports. | 11 reports |
| HR 1406 | Bills it lobbied on | W Strategies, LLC named HR 1406, “Lung Cancer Screening and Prevention Act of 2025”, in 5 lobbying reports. | 5 reports |
| HR 2300 | Bills it lobbied on | W Strategies, LLC named HR 2300, “To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes”, in 4 lobbying reports. | 4 reports |
| HR 1990 | Bills it lobbied on | W Strategies, LLC named HR 1990, “American Innovation and R&D Competitiveness Act of 2025”, in 2 lobbying reports. | 2 reports |
| Bradley Schneider | Lawmakers it funded or lobbied | Bradley Schneider leads 1 bill W Strategies, LLC lobbied on. | Leads 1 of these bills |
| Diana Harshbarger | Lawmakers it funded or lobbied | Diana Harshbarger leads 1 bill W Strategies, LLC lobbied on. | Leads 1 of these bills |
| Gregory Murphy | Lawmakers it funded or lobbied | Gregory Murphy leads 1 bill W Strategies, LLC lobbied on. | Leads 1 of these bills |
| Jodey Arrington | Lawmakers it funded or lobbied | Jodey Arrington leads 1 bill W Strategies, LLC lobbied on. | Leads 1 of these bills |
| John Joyce | Lawmakers it funded or lobbied | John Joyce leads 1 bill W Strategies, LLC lobbied on. | Leads 1 of these bills |
| Ron Estes | Lawmakers it funded or lobbied | Ron Estes leads 1 bill W Strategies, LLC lobbied on. | Leads 1 of these bills |
| Vern Buchanan | Lawmakers it funded or lobbied | Vern Buchanan leads 1 bill W Strategies, LLC lobbied on. | Leads 1 of these bills |